Comparison of a Lower-lipid Propofol Emulsion with the Standard Emulsion for Sedation during Monitored Anesthesia Care

Dajun Song, Mohamed A. Hamza, Paul F. White, Stephanie I. Byerly, Stephanie B. Jones, Amy D. Macaluso

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Background: The currently used emulsion formulations of 1% propofol contain 10% soybean oil. However, a new emulsion of 1% propofol (Ampofol) containing 50% less lipid has recently become available for clinical investigation. This study was designed to compare the pharmacodynamic properties of Ampofol with those of a standard formulation (Diprivan) when administered for intraoperative sedation. Methods: Sixty healthy outpatients undergoing minor operations with local anesthesia were randomly assigned to receive either Ampofol (n = 31) or Diprivan (n = 29) for intravenous sedation. The sedation was initiated with an intravenous loading dose of propofol, 0.75 mg/kg, followed by an initial infusion rate of 50 μg · kg -1 · min-1 to achieve an Observer's Assessment of Alertness/Sedation score of 3. The targeted level of sedation was maintained with a variable-rate propofol infusion during the operation. The onset times to achieving a sedation score of 3, the severity of pain on injection of the loading dose, intraoperative hemodynamic variables, and electroencephalographic Bispectral Index values were recorded. In addition, recovery times, postoperative pain and nausea, and patient satisfaction with the sedative medication were assessed. Results: There were no significant differences between Ampofol and Diprivan with respect to onset times, dosage requirements, Bispectral index values, hemodynamic variables, recovery times, or patient satisfaction scores. The incidence of moderate pain on injection was higher in the Ampofol group (26% vs. 7% with Diprivan; P < 0.05). Conclusions: Ampofol was equipotent to Diprivan with respect to its sedative properties during monitored anesthesia care. Although both groups received pretreatment with intravenous lidocaine, Ampofol was associated with more pain on injection.

Original languageEnglish (US)
Pages (from-to)1072-1075
Number of pages4
JournalAnesthesiology
Volume100
Issue number5
DOIs
StatePublished - May 2004

Fingerprint

Propofol
Emulsions
Anesthesia
Lipids
Hypnotics and Sedatives
Patient Satisfaction
Pain
Injections
Hemodynamics
Postoperative Nausea and Vomiting
Soybean Oil
Local Anesthesia
Postoperative Pain
Lidocaine
Outpatients
Incidence

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Comparison of a Lower-lipid Propofol Emulsion with the Standard Emulsion for Sedation during Monitored Anesthesia Care. / Song, Dajun; Hamza, Mohamed A.; White, Paul F.; Byerly, Stephanie I.; Jones, Stephanie B.; Macaluso, Amy D.

In: Anesthesiology, Vol. 100, No. 5, 05.2004, p. 1072-1075.

Research output: Contribution to journalArticle

Song, Dajun ; Hamza, Mohamed A. ; White, Paul F. ; Byerly, Stephanie I. ; Jones, Stephanie B. ; Macaluso, Amy D. / Comparison of a Lower-lipid Propofol Emulsion with the Standard Emulsion for Sedation during Monitored Anesthesia Care. In: Anesthesiology. 2004 ; Vol. 100, No. 5. pp. 1072-1075.
@article{e9d803075f6647e6a524647ea503bee0,
title = "Comparison of a Lower-lipid Propofol Emulsion with the Standard Emulsion for Sedation during Monitored Anesthesia Care",
abstract = "Background: The currently used emulsion formulations of 1{\%} propofol contain 10{\%} soybean oil. However, a new emulsion of 1{\%} propofol (Ampofol) containing 50{\%} less lipid has recently become available for clinical investigation. This study was designed to compare the pharmacodynamic properties of Ampofol with those of a standard formulation (Diprivan) when administered for intraoperative sedation. Methods: Sixty healthy outpatients undergoing minor operations with local anesthesia were randomly assigned to receive either Ampofol (n = 31) or Diprivan (n = 29) for intravenous sedation. The sedation was initiated with an intravenous loading dose of propofol, 0.75 mg/kg, followed by an initial infusion rate of 50 μg · kg -1 · min-1 to achieve an Observer's Assessment of Alertness/Sedation score of 3. The targeted level of sedation was maintained with a variable-rate propofol infusion during the operation. The onset times to achieving a sedation score of 3, the severity of pain on injection of the loading dose, intraoperative hemodynamic variables, and electroencephalographic Bispectral Index values were recorded. In addition, recovery times, postoperative pain and nausea, and patient satisfaction with the sedative medication were assessed. Results: There were no significant differences between Ampofol and Diprivan with respect to onset times, dosage requirements, Bispectral index values, hemodynamic variables, recovery times, or patient satisfaction scores. The incidence of moderate pain on injection was higher in the Ampofol group (26{\%} vs. 7{\%} with Diprivan; P < 0.05). Conclusions: Ampofol was equipotent to Diprivan with respect to its sedative properties during monitored anesthesia care. Although both groups received pretreatment with intravenous lidocaine, Ampofol was associated with more pain on injection.",
author = "Dajun Song and Hamza, {Mohamed A.} and White, {Paul F.} and Byerly, {Stephanie I.} and Jones, {Stephanie B.} and Macaluso, {Amy D.}",
year = "2004",
month = "5",
doi = "10.1097/00000542-200405000-00007",
language = "English (US)",
volume = "100",
pages = "1072--1075",
journal = "Anesthesiology",
issn = "0003-3022",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Comparison of a Lower-lipid Propofol Emulsion with the Standard Emulsion for Sedation during Monitored Anesthesia Care

AU - Song, Dajun

AU - Hamza, Mohamed A.

AU - White, Paul F.

AU - Byerly, Stephanie I.

AU - Jones, Stephanie B.

AU - Macaluso, Amy D.

PY - 2004/5

Y1 - 2004/5

N2 - Background: The currently used emulsion formulations of 1% propofol contain 10% soybean oil. However, a new emulsion of 1% propofol (Ampofol) containing 50% less lipid has recently become available for clinical investigation. This study was designed to compare the pharmacodynamic properties of Ampofol with those of a standard formulation (Diprivan) when administered for intraoperative sedation. Methods: Sixty healthy outpatients undergoing minor operations with local anesthesia were randomly assigned to receive either Ampofol (n = 31) or Diprivan (n = 29) for intravenous sedation. The sedation was initiated with an intravenous loading dose of propofol, 0.75 mg/kg, followed by an initial infusion rate of 50 μg · kg -1 · min-1 to achieve an Observer's Assessment of Alertness/Sedation score of 3. The targeted level of sedation was maintained with a variable-rate propofol infusion during the operation. The onset times to achieving a sedation score of 3, the severity of pain on injection of the loading dose, intraoperative hemodynamic variables, and electroencephalographic Bispectral Index values were recorded. In addition, recovery times, postoperative pain and nausea, and patient satisfaction with the sedative medication were assessed. Results: There were no significant differences between Ampofol and Diprivan with respect to onset times, dosage requirements, Bispectral index values, hemodynamic variables, recovery times, or patient satisfaction scores. The incidence of moderate pain on injection was higher in the Ampofol group (26% vs. 7% with Diprivan; P < 0.05). Conclusions: Ampofol was equipotent to Diprivan with respect to its sedative properties during monitored anesthesia care. Although both groups received pretreatment with intravenous lidocaine, Ampofol was associated with more pain on injection.

AB - Background: The currently used emulsion formulations of 1% propofol contain 10% soybean oil. However, a new emulsion of 1% propofol (Ampofol) containing 50% less lipid has recently become available for clinical investigation. This study was designed to compare the pharmacodynamic properties of Ampofol with those of a standard formulation (Diprivan) when administered for intraoperative sedation. Methods: Sixty healthy outpatients undergoing minor operations with local anesthesia were randomly assigned to receive either Ampofol (n = 31) or Diprivan (n = 29) for intravenous sedation. The sedation was initiated with an intravenous loading dose of propofol, 0.75 mg/kg, followed by an initial infusion rate of 50 μg · kg -1 · min-1 to achieve an Observer's Assessment of Alertness/Sedation score of 3. The targeted level of sedation was maintained with a variable-rate propofol infusion during the operation. The onset times to achieving a sedation score of 3, the severity of pain on injection of the loading dose, intraoperative hemodynamic variables, and electroencephalographic Bispectral Index values were recorded. In addition, recovery times, postoperative pain and nausea, and patient satisfaction with the sedative medication were assessed. Results: There were no significant differences between Ampofol and Diprivan with respect to onset times, dosage requirements, Bispectral index values, hemodynamic variables, recovery times, or patient satisfaction scores. The incidence of moderate pain on injection was higher in the Ampofol group (26% vs. 7% with Diprivan; P < 0.05). Conclusions: Ampofol was equipotent to Diprivan with respect to its sedative properties during monitored anesthesia care. Although both groups received pretreatment with intravenous lidocaine, Ampofol was associated with more pain on injection.

UR - http://www.scopus.com/inward/record.url?scp=2142651455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2142651455&partnerID=8YFLogxK

U2 - 10.1097/00000542-200405000-00007

DO - 10.1097/00000542-200405000-00007

M3 - Article

C2 - 15114202

AN - SCOPUS:2142651455

VL - 100

SP - 1072

EP - 1075

JO - Anesthesiology

JF - Anesthesiology

SN - 0003-3022

IS - 5

ER -